ArticleBMJ open sport & exercise medicine2025
Beyond the field: injury and illness patterns among Team USA athletes at the Paris 2024 Olympic and Paralympic Games.
Article in BMJ open sport & exercise medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The impact of injury and illness on team USA performance outcomes at the Paris 2024 summer olympic games.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractObjective: To (1) describe the incidence and characteristics of injuries and illnesses reported by Team USA athletes competing in the 2024 Paris Summer Olympic Games (PSOG) and Paralympic Games (PSPG); (2) compare injury and illness incidence between Olympic and Paralympic cohorts and (3) quantify the burden of respiratory and thermoregulatory illnesses under standard (post-COVID) public health conditions. Methods: The United States Olympic & Paralympic Committee (USOPC) Injury and Illness Surveillance system was used to document the details of all injuries and illnesses reported by any of the 862 athletes, alternates and guides competing for Team USA in the PSOG and PSPG. Illness and injury incidence per 1000 athlete-days (AD) and incidence ratios (IR) were calculated, both with 95% CI. Results: Team USA Paralympic athletes sustained 20.5 injuries per 1000 AD versus 14.6 among Olympic athletes (IR (95% CI): 1.4 (1.1 to 1.8)). Illness incidence was 15.7 per 1000 AD among Paralympic athletes versus 8.3 in Olympic athletes (IR (95% CI): 1.9 (1.4 to 2.6)). Among Team USA Paralympic athletes, injuries sustained outside of sport settings accounted for 38.5% (30/78) of all Paralympic injuries, the largest single setting category. The most common system affected by illness at both PSOG and PSPG was the respiratory system, with 7.4% of all athletes reporting a respiratory illness. Despite concerns ahead of the Games related to extreme heat, only two (0.3%) Olympic athletes and zero (0.0%) Paralympic athletes from Team USA reported a heat-related illness. Conclusion: Injury and illness rates were higher among Team USA Paralympic athletes compared with Olympic athletes during the Paris 2024 Games. Respiratory illnesses were the most frequent medical problem, despite a pre-Games prevention campaign, highlighting the need for stronger infection-control strategies at future Games. The absence of heat illness suggests current heat-mitigation measures were effective. Comprehensive injury-prevention and illness-prevention strategies are needed for both Olympic and Paralympic athletes, with additional attention to the environmental and accessibility risks that disproportionately affect Paralympic competitors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.